VUZE Medical
Software-only Guidance Solution for Spinal Surgery
Company Overview
Snapshot
Founded in March 2017 by David Tolkowsky, VUZE Medical operates with 1–10 employees. The company has secured funding across one round from Welltech Ventures. In January 2022, VUZE Medical announced U.S. FDA 510(k) clearance for its VUZE System, marking a significant regulatory milestone.
Business overview
VUZE Medical develops VUZE, a software-only intra-operative guidance solution for skeletal surgery, with a primary focus on spinal procedures. This technology aims to support the shift towards ambulatory surgical settings, reduce healthcare costs, and enhance patient comfort. The solution addresses market segments where traditional computer-assisted surgery is less suitable, offering improved accuracy and reduced radiation exposure compared to standard X-ray guidance. VUZE utilizes proprietary dynamic online image fusion software to automatically overlay surgical tool positions from 2D X-rays onto pre-surgery 3D scans in real time, operating within the Health Tech & Life Sciences sector.
Strategic signal
In October 2023, VUZE Medical announced plans to showcase its next-generation software-based guidance system for spine surgery at NASS 2023, following an FDA filing. This signals the company's continued innovation and progression towards commercialization, indicating a strong focus on bringing advanced surgical guidance technology to market after achieving regulatory milestones.
Log in to access full profile ›Company Intelligence Q&A
- What is VUZE Medical's core product?
- VUZE Medical's core product is VUZE, a software-only intra-operative guidance solution designed for skeletal surgery, particularly focusing on spinal procedures. It uses dynamic online image fusion software to enhance accuracy and reduce radiation exposure during surgery.
- When was VUZE Medical founded?
- VUZE Medical was founded in March 2017.
- Has VUZE Medical received any regulatory clearances?
- Yes, in January 2022, VUZE Medical announced U.S. FDA 510(k) clearance for its VUZE System.
- What was a strategic activity for VUZE Medical in late 2023?
- In October 2023, VUZE Medical showcased its next-generation software-based guidance system for spine surgery at NASS 2023, following an FDA filing.